Skip to Main content Skip to Navigation
Journal articles

SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA

P. Sarafidis 1 C. J. Ferro 2 E. Morales 3 A. Ortiz 4 J. Malyszko 5 R. Hojs 6 K. Khazim 7 R. Ekart 6 J. Valdivielso 8 D. Fouque 9, 10, 11 G. M. London 12 Z. Massy 13, 14 P. Ruggenenti 15 E. Porrini 16, 17 A. Wiecek 18 C. Zoccali 19 
1 Aristotle University of Thessaloniki
2 University Hospitals Birmingham [Birmingham, Royaume-Uni]
3 Hospital Universitario 12 de Octubre [Madrid]
4 UAM - Universidad Autónoma de Madrid
5 Medical University of Warsaw - Poland
6 University of Maribor
7 Galilee Medical Center [Nahariya, Israel]
8 IRBLleida - Biomedical Research Institute of Lleida [Spain]
9 CarMeN - Cardiovasculaire, métabolisme, diabétologie et nutrition
10 CHLS - Centre Hospitalier Lyon Sud [CHU - HCL]
11 Université de Lyon
12 Centre Hospitalier Manhès [Fleury-Mérogis]
13 Hôpital Ambroise Paré [AP-HP]
14 UVSQ - Université de Versailles Saint-Quentin-en-Yvelines
15 Azienda Ospedaliera Ospedale Papa Giovanni XXIII [Bergamo, Italy]
16 ULL - Universidad de La Laguna [Tenerife - SP]
17 Hospital Universitario De Canarias
18 University of Silesia in Katowice
19 Ospedali riuniti di Reggio Calabria [Reggio Calabria, Italy]
Abstract : No abstract available
Document type :
Journal articles
Complete list of metadata
https://www.hal.inserm.fr/inserm-03261177
Contributor : laboratoire CarMeN Connect in order to contact the contributor
Submitted on : Tuesday, June 15, 2021 - 2:57:16 PM
Last modification on : Monday, May 30, 2022 - 4:16:03 PM
Long-term archiving on: : Thursday, September 16, 2021 - 6:50:52 PM

File

Vignette du document
gfz137.pdf

Licence

Distributed under a Creative Commons Attribution - NonCommercial 4.0 International License

Identifiers

Collections

INSERM | HCL | UNIV-LYON1 | INSA-LYON | CHLS | UVSQ | CARMEN | INSA-GROUPE | UDL | INRAE

Citation

P. Sarafidis, C. J. Ferro, E. Morales, A. Ortiz, J. Malyszko, et al.. SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA. Nephrology Dialysis Transplantation, Oxford University Press, 2020, 35 (10), pp.1825. ⟨10.1093/ndt/gfz137⟩. ⟨inserm-03261177⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

17

Files downloads

248